Search for: "Janssen v. Janssen" Results 321 - 340 of 385
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Dec 2010, 2:17 am by Kelly
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not patentable… [read post]
6 Jun 2017, 1:00 am by Rik Lambers
The District Court first considered relevant decisions from the German courts (LG Hamburg 2 April 2015, Warner-Lambert v A Pharma; OLG Düsseldorf 1 December 2015, KKH v Pfizer), and UK court (England and Wales Court of Appeal 28 May 2015 and 13 October 2016, Warner-Lambert v Actavis). [read post]
6 Dec 2021, 6:24 am by Lisa Larrimore Ouellette
Phase 2/3 clinical trials began in February 2021 for Pfizer/BioNTech and Janssen and included pregnant people. [read post]
16 Apr 2014, 4:36 pm
Ortho-McNeil-Janssen Pharms., Inc., No. 1:09 oe 40023, 2014 U.S. [read post]
18 Nov 2016, 12:44 am by John Collins
The judge held that the “undue burden” concept in English law (particularly as outlined by Arnold J in Eli Lilly v Janssen in 2014) was not particularly helpful under Australian law. [read post]
25 Jan 2017, 10:48 pm
  Birss J agreed with Floyd J in Actavis v Janssen [2008] EWHC 1422 (Pat) that the presence of another fairly remote possibility did not preclude a finding of “inevitable result”. [read post]
7 Mar 2024, 5:00 am by Vincent Joralemon
For example, Spravato, Janssen Pharmaceutical’s intranasal S-ketamine product, comes with a REMS that mandates the product can only be given in an approved facility. [read post]
10 Jun 2009, 10:00 pm
Janssen Pharmaceutica, Inc., 1997 WL 201571, at *9 (N.D. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
13 May 2010, 12:27 pm by Bexis
Janssen Pharmaceutica, Inc., 288 Fed. [read post]